BeyondSpring (BYSI) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on BeyondSpring (BYSI) is Moderate Underperform.

The composite score behind that read is -0.33, weighing +0.30 of bullish evidence against -0.35 bearish.

BeyondSpring last closed at $0.69, -12.66% on the session.

Against the IVW growth benchmark the position is -13.27% over the forecast window.

The read is built from 12 underlying insights — 1 bullish and 11 bearish.

Agreement across those insights is 92%.

17 graded predictions for BYSI so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks BeyondSpring in the 82nd percentile on return on equity, where 100 is best.

BeyondSpring is classified under Health Care / Biotechnology, with a market capitalisation of $32.32M.

StockMap tracks BeyondSpring as the 310th largest of the 365 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 190 Moderate Underperform, 164 Neutral and 11 Strong Underperform.

On that composite BeyondSpring ranks 285th of 365 in the group, against a group median of -0.21.

Other Health Care stocks

BeyondSpring (BYSI) — StockMap 2-week forecast & tracked accuracy